TIMI 31

TIMI 31 evaluated the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST-elevation myocardial infarction.

DOWNLOAD SLIDE SET (PDF)

Key Study Publications

Gibson, C. M., Zorkun, C., Molhoek, P., Zmudka, K., Greenberg, M., Mueller, H., Wesdorp, J., Louwerenburg, H., Niederman, A., Westenburg, J., Bikkina, M., Batty, J., de Winter, J., Murphy, S. A., McCabe, C. H. Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: results of the TIMI 31 trial J Thromb Thrombolysis. 2006;22(1):13-21.